Resmed Inc. buy KeyCorp
Start price
31.01.25
/
50%
€232.00
Target price
31.01.26
€269.28
Performance (%)
-4.82%
Price
05.12.25
€220.30
Summary
This prediction is currently active. With a performance of -4.82%, the BUY prediction for Resmed Inc. by KeyCorp is down slightly. Dividends of €0.51 are taken into consideration when calculating the performance. This prediction currently runs until 31.01.26. The prediction end date can be changed by KeyCorp at any time. KeyCorp has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Resmed Inc. | -0.181% | -0.181% |
| iShares Core DAX® | 0.760% | -0.301% |
| iShares Nasdaq 100 | 0.732% | -1.001% |
| iShares Nikkei 225® | 1.025% | -3.621% |
| iShares S&P 500 | -0.036% | -0.194% |
Comments by KeyCorp for this prediction
In the thread Resmed Inc. diskutieren
ResMed Inc. (NYSE: RMD) had its price target raised by analysts at KeyCorp from $266.00 to $280.00. They now have an "overweight" rating on the stock.
Ratings data for RMD provided by MarketBeat